Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Company Profile for BioLeap, LLC.


BioLeap offers a highly cost-effective lead identification and optimization service using the next generation of structure-based design.

* BioLeap's technology determines the location, orientation, and binding affinities of chemical moieties in relation to a target protein. These are used to build or modify ligands that achieve design goals such as potency, bioavailability bioavailability /bio·avail·a·bil·i·ty/ (bi?o-ah-val?ah-bil´i-te) the degree to which a drug or other substance becomes available to the target tissue after administration.

bi·o·a·vail·a·bil·i·ty
n.
, selectivity selectivity /se·lec·tiv·i·ty/ (se-lek-tiv´i-te) in pharmacology, the degree to which a dose of a drug produces the desired effect in relation to adverse effects.

selectivity

1.
, or insensitivity to mutations.

* This information allows our chemists to access a very large chemical diversity that is relevant to the target receptor.

* By predicting the impact on affinity of chemical modifications In biochemistry, chemical modification is the technique of chemically reacting a protein or nucleic acid with chemical reagents. Chemical modification can have several goals, such as
  • to identify which parts of the molecule are exposed to solvent ("foot printing");
, only a small number of very specific compounds need to be synthesized and tested.

* With a small number of compounds, it is economical to do a broader range of bioassays, such as in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment.

in vi·tro
adj.
In an artificial environment outside a living organism.
, cell, and ADME ADME Absorption, Distribution, Metabolism, and Excretion
ADME Association of Destination Management Executives
ADME Active Duty Medical Extension
 assays, at each stage of optimization. This results in faster optimization and more information from each cycle.

Bio-assays early = an immediate focus on drugability = higher success; Less wet chemistry = more "shots on goal" per dollar invested; Without HTS HTS Heights
HTS Harmonized Tariff System
HTS High Throughput Screening (biomolecular assay screening)
HTS High-Throughput Screening (Pharmaceutical Industry)
HTS Harmonized Tariff Schedule
 or virtual library screening.
Company:               >
BioLeap, LLC
                       >

Headquarters Address:  >
346A Lurgan Road
                       >
New Hope, PA 18938
                       >

Main Telephone:        >
2153712874
                       >

Website:               >
www.bioleap.com
                       >

Type of Organization:  >
Private
                       >

Industry:              >
Biotechnology
                       >

Key Executives:        >
EVP: Gerald Evans
                       >

Public Relations       >

Contact:               >
Gerry Evans
Phone:                 >
2153712874
Email:                 >
ghe@bioleap.com
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 13, 2008
Words:204
Previous Article:Company Profile for Emergo Group, Inc.
Next Article:Company Profile for Docmos.



Related Articles
RBCOR, LLC. (Company Profiles 2003).
Contract Converting, LLC.
Kurz Transfer Products LLC.
Sekisui TA Industries, LLC.
Company Profile for All American Homes LLC.
Company Profile for Microvi Biotech, LLC.
Company Profile for PupGear Corporation LLC.
Company Profile for Vmeals, LLC.
Company Profile for NASCENT Technology, LLC.
Dr. Raymond Salemme Joins BioLeap's Advisory Board.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles